Skip to main content

Table 2 miRNAs differentially expressed between progressing-LGD leukoplakias and non-progressing-LGD leukoplakias

From: Progress risk assessment of oral premalignant lesions with saliva miRNA analysis

 

Mean intensity in

Mean intensity in

   

miRNA

Non-progressing LGDs

Progressing LGDs

Fold change

Unadjusted p value

FDR

miR-10b-5p

10.2689

13.7939

11.51↑

0.008

0.069

miR-99a-5p

10.9423

8.1768

6.80↓

0.011

0.069

miR-99b-5p

16.3981

12.1692

18.75↓

0.003

0.016

miR-145-5p

13.3692

9.6968

12.75↓

0.011

0.069

miR-100-5p

11.9107

8.8512

8.33↓

0.011

0.0698

miR-125b-5p

10.9423

8.1768

6.80↓

0.011

0.0698

miR-181b

9.9163

6.1030

14.05↓

0.016

0.069

miR-181c

20.6273

16.6825

15.40↓

0.011

0.069

miR-197-3p

16.4423

12.3639

16.89↓

0.042

0.128

miR-331-3p

10.9681

8.1938

6.84↓

0.010

0.069

miR-15a-5p

16.5175

12.8715

12.51↓

0.002

0.056

miR-708

8.8610

12.4334

11.89↑

0.014

0.069

miR-150-5p

7.9801

5.4854

5.63↓

0.002

0.0567

miR-30e-3p

6.6441

10.9956

20.41↑

0.002

0.056

miR-30a-3p

15.2221

17.1464

3.80↑

0.049

0.985

miR-21

7.1456

9.5243

5.20↑

0.049

0.985

let-7a-5p

20.3130

17.7931

5.74↓

0.039

0.985

miR-335-5p

9.2299

10.2837

2.08↑

0.039

0.995

miR-144*

11.5283

15.1400

12.22↑

0.005

0.057

miR-25-3p

8.8177

12.5057

12.88↑

0 .017

0.069

miR-19a-3p

5.3255

8.5336

9.24↑

0.007

0.066

miR-660-5p

7.8916

12.6950

27.92↑

0.020

0.076

miR-140-5p

11.1943

15.2157

16.23↑

0.012

0.069

miR-590-5p

7.4825

11.4638

15.79↑

0.004

0.057

miR-9

21.1533

17.9955

8.92↓

0.039

0.915